| Literature DB >> 35099630 |
Carolina Casado-Robles1, Jesús Viciana1, Santiago Guijarro-Romero1, Daniel Mayorga-Vega2.
Abstract
BACKGROUND: The popularity of consumer-wearable activity trackers has led the scientific community to conduct an increasing number of intervention studies integrating them to promote physical activity (PA) and to reduce sedentary behavior (SB) levels among school-aged children. Therefore, the aim of the present study was to estimate the effects of consumer-wearable activity tracker-based programs on daily objectively measured PA and SB among apparently healthy school-aged children, as well as to compare the influence of participants' and programs' characteristics.Entities:
Keywords: Activity monitor; Adolescents; Behavior change; Children; Fitness tracker; Goal-setting; Intervention; Self-monitoring; Wearable activity tracker
Year: 2022 PMID: 35099630 PMCID: PMC8804065 DOI: 10.1186/s40798-021-00407-6
Source DB: PubMed Journal: Sports Med Open ISSN: 2198-9761
Fig. 1Flow diagram of the study selection process. PA = physical activity. Note The sum of publications included in the meta-analysis for each variable is greater than 40 because some studies reported outcomes for different variables. *The number of reports excluded for each reason has not been included because a report could have been removed for only one reason, but at the same time could meet many other reasons for exclusion, and therefore including them would not really give accurate information on the reports removed
Characteristics of included studies in the systematic review
| Study | Participants characteristics | Study design | Intervention characteristics | Outcome parameter (instrument)e | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of participantsa | Ageb | Sexc | Tracker | Durationd | Group | Goal-setting | Diary | Counseling | Reminder | Motivation | Exercise | |||
| Aksornsri [ | EG1: 40 (39) | 11.4 (8–13) | Both | Non-CT | Wrist | 4 | EG1 | Static | No | Yes | Yes | No | Yes | Steps (wearable) |
| Baldursdóttir [ | CG: 57 (54); EG1: 61 (57); EG2: 58 (57) | 16.0 (15–16) | Both | CRCT | Hip | 3 | EG1 | Adaptive | Yes | Yes | No | No | No | Steps (wearable) |
| EG2 | Adaptive | No | Yes | No | No | No | ||||||||
| Baldursdottir et al. [ | CG: 46 (27); EG1: 38 (26) | 16.0 (16–16) | Both | CRCT | Hip | 3 | EG1 | Adaptive | Yes | Yes | Yes | Yes | No | Steps (wearable) |
| Bronikowski et al. [ | EG1: 100 (100); EG2: 93 (93) | 14.8 (10–17) | Both | Non-CT | Wrist | 8 | EG1 | Static | No | No | No | No | No | Steps (wearable) |
| EG2 | No | No | No | No | No | No | ||||||||
| Corepal et al. [ | CG: 82 (64); EG1: 142 (126) | 13.0 (12–14) | Both | CRCT | Hip | 22 | EG1 | Adaptive | Yes | Yes | No | Yes | No | MVPA; SB; Steps; and Total PA (accelerometer) |
| Corr et al. [ | EG1: 31 (17) | 14.0 (12–16) | Females | Non-CT | Hip | 6 | EG1 | Adaptive | Yes | Yes | Yes | Yes | No | Steps (wearable) |
| Corr and Murtagh [ | EG1: 31 (10) | 16.0 (15–17) | Females | Non-CT | Hip | 6 | EG1 | Adaptive | Yes | Yes | No | No | Yes | Steps (wearable) |
| Duck et al. [ | CG: 18 (14); EG1: 17 (13) | 9.2 (9–10) | Both | CRCT | Wrist | 10 | EG1 | No | No | No | No | Yes | No | MVPA (accelerometer) |
| Duncan et al. [ | EG1: 59 (59) | 10.7 (10–11) | Both | Non-CT | Hip | 4 | EG1 | Static | Yes | Yes | No | Yes | No | Steps (wearable) |
| Ermetici et al. [ | EG1: 181 (167) | 12.5 (11–15) | Both | Non-CT | Hip | 84 | EG1 | No | No | Yes | Yes | No | No | Steps (wearable) |
| Evans et al. [ | EG1: 32 (32) | 10.0 (10–11) | Both | Non-CT | Hip | 4 | EG1 | Static | Yes | Yes | No | Yes | No | Steps (wearable) |
| Evans et al. [ | CG: 10 (10); EG1: 19 (19); EG2: 13 (13) | 12.3 (11–12) | Both | Non-RCT | Wrist | 6 | EG1 | Static | Yes | Yes | No | Yes | No | Steps and MVPA (accelerometer) |
| EG2 | No | No | No | No | No | No | ||||||||
| Eyre et al. [ | CG: 40 (30); EG1: 94 (55) | 10.0 (9–12) | Both | CRCT | Hip | 6 | EG1 | Static | Yes | Yes | No | Yes | Yes | Steps (wearable) |
| Finkelstein et al. [ | CG: 138 (89); EG1: 147 (145) | 8.2 (6–12) | Both | CRCT | Hip | 36 | EG1 | Static | No | Yes | No | Yes | No | Steps (wearable) |
| Galy et al. [ | EG1: 24 (15) | 11.9 (12–14) | Both | Non-CT | Wrist | 4 | EG1 | No | No | Yes | No | Yes | Yes | Steps (wearable) |
| Gaudet et al. [ | CG: 23 (16); EG1: 23 (16) | 13.0 (13–14) | Both | CRCT | Wrist | 7 | EG1 | No | No | No | No | No | No | MVPA and SB (accelerometer); Steps and MVPA (wearable) |
| Grao-Cruces et al. [ | EG1: 142 (66) | 11.4 (11–12) | Both | Non-CT | Hip | 6 | EG1 | Static | Yes | No | No | Yes | No | Steps (wearable) |
| Groffik et al. [ | EG1: 71 (64) | 17.9 (17–18) | Both | Non-CT | Hip | 3 | EG1 | No | Yes | No | No | No | No | Steps (wearable) |
| Guagliano et al. [ | CG: 25 (23); EG1: 24 (18); EG2: 24 (15) | 9.3 (7–11) | Both | CRCT | Hip | 8 | EG1 | No | No | Yes | No | Yes | No | MVPA and SB (accelerometer) |
| EG2 | Adaptive | Yes | Yes | Yes | Yes | No | ||||||||
| Hardman et al. [ | CG: 18 (15); EG1: 14 (14) | 10.6 (10–11) | Females | CRCT | Hip | 12 | EG1 | Adaptive | Yes | No | No | Yes | No | Steps (wearable) |
| Hardman et al. [ | EG1: 81 (51); EG2: 119 (67); EG3: 186 (118) | 9.0 (7–11) | Both | Non-CT | Hip | 17 | EG1 | No | No | No | No | No | No | Steps (wearable) |
| EG2 | Adaptive | Yes | Yes | Yes | Yes | No | ||||||||
| EG3 | Adaptive | Yes | Yes | Yes | Yes | No | ||||||||
| Horne et al. [ | CG: 53 (51); EG1: 47 (38) | 10.0 (9–11) | Both | CRCT | Hip | 16 | EG1 | Adaptive | Yes | Yes | Yes | Yes | No | Steps (wearable) |
| Jago et al. [ | CG: 55 (51); EG1: 65 (64) | 13.0 (10–14) | Males | CRCT | Hip | 9 | EG1 | Static | No | Yes | No | No | Yes | SB; MVPA; and Total PA (accelerometer) |
| Jago et al. [ | CG: 130 (88); EG1: 103 (86) | |||||||||||||
| Jauho et al. [ | CG: 139 (38); EG1: 137 (25) | 17.9 (17–18) | Males | RCT | Wrist | 12 | EG1 | No | No | No | No | No | No | MVPA and SB (wearable) |
| Kantanista et al. [ | EG1: 26 (26); EG2: 56 (56) | 17.2 (16–18) | Females | Non-CT | Hip | 7 | EG1 | No | No | No | No | No | No | Steps (wearable) |
| EG2 | Adaptive | No | No | No | No | No | ||||||||
| Kerner et al. [ | EG1: 62 (28) | 14.5 (14–15) | Both | Non-CT | Wrist | 5 | EG1 | No | No | No | No | No | No | MVPA (accelerometer) |
| Larsen et al. [ | EG1: 21 (19) | 14.7 (12–18) | Females | Non-CT | Hip | 12 | EG1 | No | Yes | Yes | Yes | Yes | No | MVPA (accelerometer) |
| Leinonen et al. [ | CG: 246 (80); EG1: 250 (87) | 17.8 (17–18) | Males | RCT | Wrist | 26 | EG1 | Static | No | Yes | No | Yes | No | MVPA and SB (wearable) |
| Linck [ | CG: 22 (17); EG1: 22 (18) | 16.6 (14–18) | Females | RCT | Hip | 12 | EG1 | Adaptive | Yes | No | No | No | No | Steps (wearable) |
| Lubans and Morgan [ | CG: 66 (52); EG1: 50 (45) | 14.2 (14–15) | Both | CRCT | Hip | 8 | EG1 | Adaptive | Yes | Yes | No | Yes | Yes | Steps (wearable) |
| Lubans et al. [ | CG: 66 (52); EG1: 58 (50) | 14.1 (13–18) | Both | CRCT | Hip | 24 | EG1 | Adaptive | Yes | Yes | Yes | Yes | Yes | Steps (wearable) |
| Lubans et al. [ | CG: 50 (50); EG1: 50 (50) | 14.3 (14–15) | Males | CRCT | Hip | 24 | EG1 | Adaptive | Yes | Yes | No | No | Yes | Steps (wearable) |
| Macias-Cervantes et al. [ | CG: 38 (30); EG1: 38 (32) | 7.8 (6–9) | Both | RCT | Hip | 12 | EG1 | Adaptive | No | Yes | No | No | Yes | Steps (wearable) |
| Morris et al. [ | CG: 72 (31); EG1: 82 (52) | 9.9 (9–10) | Both | CRCT | Hip | 6 | EG1 | Adaptive | No | No | No | No | No | MVPA; SB; and Total PA (accelerometer) |
| Newton et al. [ | EG1: 14 (14); EG2: 13 (13) | 8.7 (6–10) | Both | Non-CT | Hip | 12 | EG1 | Adaptive | No | No | No | Yes | No | Steps (wearable) |
| EG2 | Adaptive | No | Yes | Yes | Yes | No | ||||||||
| Remmert et al. [ | EG1: 10 (6); EG2: 10 (9) | 12 (12–12) | Both | Non-CT | Wrist | 12 | EG1 | No | No | No | No | No | No | MVPA (accelerometer); Steps and MVPA (wearable) |
| EG2 | Adaptive | No | Yes | No | No | Yes | ||||||||
| Routen et al. [ | EG1: 17 (14); EG2: 26 (20); EG3: 25 (16) | 11.2 (11–12) | Both | Non-CT | Hip | 3 | EG1 | No | No | No | No | No | No | MVPA and Total PA (accelerometer) |
| EG2 | Adaptive | Yes | No | No | No | No | ||||||||
| EG3 | Adaptive | Yes | No | No | No | No | ||||||||
| Schofield et al. [ | CG: 30 (24); EG1: 27 (23); EG2: 28 (21) | 15.8 (15–18) | Females | CRCT | Hip | 12 | EG1 | Adaptive | Yes | Yes | Yes | No | No | Steps (wearable) |
| EG2 | Adaptive | Yes | Yes | Yes | No | No | ||||||||
| Shapiro et al. [ | EG1: 18 (13); EG2: 18 (7) | 8.7 (5–13) | Both | Non-CT | Hip | 8 | EG1 | Static | Yes | Yes | Yes | Yes | No | Steps (wearable) |
| EG2 | Static | Yes | Yes | No | Yes | No | ||||||||
| Shimon and Petlichkoff [ | CG: 62 (36); EG1: 72 (43); EG2: 60 (34) | 13.1 (12–14) | Both | CRCT | Hip | 4 | EG1 | Adaptive | Yes | Yes | No | No | No | Steps (wearable) |
| EG2 | No | Yes | No | No | No | No | ||||||||
| Shore et al. [ | EG1: 57 (46); EG2: 56 (46) | 11.9 (11–12) | Both | Non-CT | Hip | 6 | EG1 | Static | Yes | Yes | Yes | Yes | No | Steps (wearable) |
| EG2 | No | Yes | No | No | No | No | ||||||||
| Smith et al. [ | CG: 180 (154); EG1: 181 (139) | 12.7 (12–14) | Males | CRCT | Hip | 20 | EG1 | Adaptive | Yes | Yes | Yes | Yes | Yes | Total PA and MVPA (accelerometer) |
| Thompson et al. [ | CG: 40 (34); EG1: 40 (36); EG2: 40 (31); EG3: 40 (37) | 15.2 (14–17) | Both | RCT | Hip | 12 | EG1 | No | No | Yes | No | No | No | MVPA and Steps (accelerometer) |
| EG2 | No | No | Yes | Yes | No | No | ||||||||
| EG3 | No | No | Yes | Yes | No | No | ||||||||
| Wang [ | EG1: 34 (24); EG2: 32 (22) | 13.5 (13–14) | Females | Non-CT | Hip | 6 | EG1 | Adaptive | Yes | Yes | No | No | No | Steps (wearable) |
| EG2 | No | Yes | No | No | No | No | ||||||||
| Zizzi et al. [ | EG1: 84 (68); EG2: 81 (60) | 16 (14–18) | Both | Non-CT | Hip | 3 | EG1 | No | Yes | Yes | No | No | No | Steps (wearable) |
| EG2 | No | Yes | No | No | No | No | ||||||||
CG = control group; EG = experimental group; CT = controlled trial; CRCT = cluster randomized controlled trial; RCT = randomized controlled trial; PA = physical Activity; MVPA = moderate-to-vigorous physical activity; SB = sedentary behavior.
aNumber of participants are reported as “group: initial number (final number)”
bAge is reported as “mean (minimum–maximum)” in years
cBoth means that includes males and females
dDuration is reported in number of weeks
eWearable correspond to the same wrist-worn or hip-worn consumer-wearable activity trackers used in the intervention. Accelerometer correspond to research-grade activity trackers
fStudies included in the meta-analysis
Fig. 2Funnel plots of standard error by standard differences in means (d) comparing consumer-wearable activity tracker-based programs effects on A daily total steps, and B moderate-to-vigorous physical activity
Fig. 3Forest plot of standardized mean differences (d) comparing consumer-wearable activity tracker-based programs effects on daily total steps. Note A positive d value means that the program favorably increased participants’ daily total steps; * p < 0.001
Fig. 4Forest plot of standardized mean differences (d) comparing consumer-wearable activity tracker-based programs effects on daily moderate-to-vigorous physical activity. Note A positive d value means that the program favorably increased participants’ daily moderate-to-vigorous physical activity; * p < 0.001
Fig. 5Forest plot of standardized mean differences (d) comparing consumer-wearable activity tracker-based programs effects on daily total physical activity. Note A positive d value means that the program favorably increased participants’ daily total physical activity; * p = 0.009)
Fig. 6Forest plot of standardized mean differences (d) comparing consumer-wearable activity tracker-based programs effects on daily sedentary behavior. Note A positive d value means that the program unfavorably increased participants’ daily sedentary behavior; * p = 0.011
Fig. 7Meta-regression scatterplots of standard differences in means (d) comparing consumer-wearable activity tracker-based programs effects on daily total steps regarding A school-aged children’s physical activity levels, B strategies included in the program, C duration, and D school-aged children’s age
Fig. 8Meta-regression scatterplots of standard differences in means (d) comparing consumer-wearable activity tracker-based programs effects on daily moderate-to-vigorous physical activity regarding A school-aged children’s physical activity levels, B strategies included in the program, C duration, and D school-aged children’s age